Search Results - Hong-Hong Yan
- Showing 1 - 14 results of 14
-
1
Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer by Jia-Yi Deng, Ming Gao, Xue Fan, Hong-Hong Yan, Wei-Chi Luo, Ming-Yi Yang, Xiao-Rong Yang, Zhi-Hong Chen, Chong-Rui Xu, Qing Zhou
Published in Cancer Immunology, Immunotherapy (2025-04-01)Get full text
Article -
2
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients by Hong‐xia Tian, Zhi‐hong Chen, Guang‐Ling Jie, Zhen Wang, Hong‐hong Yan, Si‐pei Wu, Shui‐lian Zhang, Dan‐xia Lu, Xu‐chao Zhang, Yi‐long Wu
Published in Cancer Medicine (2023-01-01)Get full text
Article -
3
Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation by Jie Huang, Shi‐Ling Zhang, Chao Zhang, Weiye Huang, Zhenhua Zhang, Yu‐Qing Chen, Jun‐Wei Su, Hong‐Hong Yan, Hua‐Jun Chen, Jin‐Ji Yang, Junjian Wang, Yi‐Long Wu
Published in Clinical and Translational Medicine (2024-05-01)Get full text
Article -
4
Three‐dimensional printed navigational template for localizing small pulmonary nodules: A case‐controlled study by Rui Fu, Yun‐Fei Chai, Jia‐Tao Zhang, Tao Zhang, Xiao‐Kun Chen, Song Dong, Hong‐Hong Yan, Xue‐Ning Yang, Mei‐Ping Huang, Yi‐Long Wu, Jian Zhuang, Wen‐Zhao Zhong
Published in Thoracic Cancer (2020-09-01)Get full text
Article -
5
Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial by Qing Zhou, Jin-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang, Hong-Hong Yan, Chong-Rui Xu, Jian Su, Hua-Jun Chen, Hai-Yan Tu, Wen-Zhao Zhong, Xue-Ning Yang, Yi-Long Wu
Published in Journal of Hematology & Oncology (2016-09-01)Get full text
Article -
6
Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study by Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao, Yi-Chen Zhang, Xu-Chao Zhang, Jian Su, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Published in Therapeutic Advances in Medical Oncology (2024-02-01)Get full text
Article -
7
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study by Jian Wang, Yi-Long Wu, Xue Bai, De-Hua Wu, Si-Cong Ma, Xin-Ran Tang, Shuai Kang, Qiang John Fu, Chuan-Hui Cao, He-San Luo, Yu-Han Chen, Hong-Bo Zhu, Hong-Hong Yan, Zhong-Yi Dong
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
8
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression by Rui-Lian Chen, Jun Zhao, Xu-Chao Zhang, Na-Na Lou, Hua-Jun Chen, Xue Yang, Jian Su, Zhi Xie, Qing Zhou, Hai-Yan Tu, Wen-Zhao Zhong, Hong-Hong Yan, Wei-Bang Guo, Yi-Long Wu, Jin-Ji Yang
Published in BMC Cancer (2018-11-01)Get full text
Article -
9
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients by Zhen Wang, Xu-Chao Zhang, Wei-Neng Feng, Li Zhang, Xiao-Qing Liu, Wei-Bang Guo, Yan-Ming Deng, Qing-Feng Zou, Jin-Ji Yang, Qing Zhou, Bin-Chao Wang, Hua-Jun Chen, Hai-Yan Tu, Hong-Hong Yan, Yi-Long Wu
Published in Therapeutic Advances in Medical Oncology (2023-04-01)Get full text
Article -
10
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma by Hao Sun, Si-Yang Liu, Jia-Ying Zhou, Jin-Tian Xu, Huang-Kai Zhang, Hong-Hong Yan, Jiao-Jiao Huan, Ping-Ping Dai, Chong-Rui Xu, Jian Su, Yan-Fang Guan, Xin Yi, Rong-Shan Yu, Wen-Zhao Zhong, Yi-Long Wu
Published in EBioMedicine (2020-10-01)Get full text
Article -
11
Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images by Ri-qiang Liao, An-wei Li, Hong-hong Yan, Jun-tao Lin, Si-yang Liu, Jing-wen Wang, Jian-sheng Fang, Hong-bo Liu, Yong-he Hou, Chao Song, Hui-fang Yang, Bin Li, Ben-yuan Jiang, Song Dong, Qiang Nie, Wen-zhao Zhong, Yi-long Wu, Xue-ning Yang
Published in Frontiers in Oncology (2022-10-01)Get full text
Article -
12
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study by Si-Yang Liu, Song Dong, Xue-Ning Yang, Ri-Qiang Liao, Ben-Yuan Jiang, Qun Wang, Xiao-Song Ben, Gui-Bin Qiao, Jun-Tao Lin, Hong-Hong Yan, Li-Xu Yan, Qiang Nie, Hai-Yan Tu, Bin-Chao Wang, Jin-Ji Yang, Qing Zhou, Hong-Rui Li, Ke Liu, Wendy Wu, Si-Yang Maggie Liu, Wen-Zhao Zhong, Yi-Long Wu
Published in Signal Transduction and Targeted Therapy (2023-12-01)Get full text
Article -
13
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma by Jia-Xin Lin, PhD, Kai Yin, PhD, Li-Xu Yan, PhD, Mei-Mei Zheng, PhD, Yang-Si Li, PhD, Shi-Ling Zhang, MS, Kang-Hui Zeng, MS, Hong-Hong Yan, MS, Hai-Yan Tu, PhD, Zhi-Hong Chen, MS, Xu-Chao Zhang, PhD, Qing Zhou, PhD, Jin-Ji Yang, PhD, Ben-Yuan Jiang, PhD, Qing-Ling Zhang, PhD, Yi-Long Wu, MD
Published in JTO Clinical and Research Reports (2024-09-01)Get full text
Article -
14
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection by Song Dong, PhD, Bingfa Yan, PhD, Si-Yang Liu, PhD, Xuan Gao, PhD, Hui-Zhao Hong, MD, Hong-Ji Li, MD, Wei Gao, PhD, Hong-Hong Yan, PhD, Si-Yang Maggie Liu, PhD, Hai-Yan Tu, PhD, Yi Pan, PhD, Qing Zhou, PhD, Xue-Ning Yang, PhD, Xue-Feng Xia, PhD, Xin Yi, PhD, Wen-Zhao Zhong, PhD, Yi-Long Wu, MD, Jia-Tao Zhang, PhD
Published in JTO Clinical and Research Reports (2025-01-01)Get full text
Article
